Liposomes are microscopic vesicles made up of lipid bilayers that have revolutionized drug delivery and therapeutic treatments. First discovered in the 1960s, liposomes have since gained prominence for their biocompatibility, ability to encapsulate both hydrophilic and hydrophobic drugs, and targeted delivery potential. As the demand for more efficient and safer drug delivery systems increases, liposomes have emerged as a leading nanotechnology in pharmaceuticals, cosmetics, and vaccine development. https://specnova.com/

The Antibody Drug Conjugates Market is gaining remarkable traction as pharmaceutical innovations continue to reshape the landscape of oncology. Antibody-drug conjugates (ADCs) represent a cutting-edge class of biopharmaceuticals that combine the targeting capabilities of monoclonal antibodies with the potent cell-killing ability of cytotoxic drugs. This revolutionary approach to cancer treatment offers targeted drug delivery, reducing side effects and enhancing efficacy making ADCs a game changer in modern medicine. https://wemarketresearch.com/reports/antibody-drug-conjugates-market/132